Glutamatergic modulation of subcortical motor and limbic circuits.
Healy
D J
DJ
Department of Psychiatry, University of Michigan, Ann Arbor 48109-0720, USA. drdan@umich.edu
Meador-Woodruff
J H
JH
D018750:6-Cyano-7-nitroquinoxaline-2,3-dione / Q000494:pharmacology*; D000818:Animals; D014151:Anti-Anxiety Agents / Q000494:pharmacology*; D001569:Benzodiazepines; D018691:Excitatory Amino Acid Antagonists / Q000494:pharmacology*; D005786:Gene Expression Regulation / Q000187:drug effects; D018698:Glutamic Acid / Q000502:physiology*; D008032:Limbic System / Q000187:drug effects / Q000502:physiology*; D008297:Male; D009044:Motor Cortex / Q000187:drug effects / Q000502:physiology*; D051381:Rats; D017207:Rats, Sprague-Dawley; D018091:Receptors, AMPA / Q000037:antagonists & inhibitors; D017448:Receptors, Dopamine D2 / Q000235:genetics*; D018092:Kainic Acid Receptors / Q000037:antagonists & inhibitors
D018750:6-Cyano-7-nitroquinoxaline-2,3-dione; D014151:Anti-Anxiety Agents; D001569:Benzodiazepines; D018691:Excitatory Amino Acid Antagonists; D018698:Glutamic Acid; D018091:Receptors, AMPA; D017448:Receptors, Dopamine D2; D018092:Kainic Acid Receptors; C061950:GYKI 52466